EyePoint Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
EyePoint Pharmaceuticals, Inc.
CIK #0001314102
EDGAR Form CIK 2011 - 2025
10-K [0001314102]
10-Q [0001314102]
3 [0001314102]
4 [0001314102]
5 [0001314102]
8-K [0001314102]
D [0001314102]
SC 13D [0001314102]
SC 13G [0001314102]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Eyepoint Pharmaceuticals Inc [2024-11-08]
TCG Crossover GP II LLC Eyepoint Pharmaceuticals Inc [2024-11-07]
Federated Hermes Inc Eyepoint Pharmaceuticals Inc [2024-11-06]
BlackRock Inc Eyepoint Pharmaceuticals Inc [2024-10-22]
Adage Capital Management LP Eyepoint Pharmaceuticals Inc [2024-04-30]
Price T Rowe Associates Inc /MD/ Eyepoint Pharmaceuticals Inc [2024-02-14]
Franklin Resources Inc Eyepoint Pharmaceuticals Inc [2022-02-03]
RA Capital Management LP Eyepoint Pharmaceuticals Inc [2021-08-13]
Suvretta Capital Management LLC Eyepoint Pharmaceuticals Inc [2021-07-26]
Adage Capital Partners GP LLC Eyepoint Pharmaceuticals Inc [2021-02-12]
View All
Form 3/4/5 Subject 2011 - 2025
Zaderej Karen L.
EyePoint Pharmaceuticals, Inc.
Duker Jay S.
Lurker Nancy
Elston George
Sanders Reginald J.
Landis John B.
Hassan Fred
ANDO Goran
Duty Stuart
View All
Terms | Privacy | Guide
tony@aum13f.com